Skip to main content
Premium Trial:

Request an Annual Quote

Gentel Places First Protein Array Reader

NEW YORK (GenomeWeb News) – Gentel Biosciences said yesterday that it has placed its first protein array reader system with the Centre for Proteomic and Genomic Research in Cape Town, South Africa.

Gentel’s APiX Colorimetric Protein Array Reader integrates colorimetric detection technology with a newly developed 96-well plate microarray format, called APiX 96. The firm’s transparent nitrocellulose-coated plastic substrate serves as the surface chemistry for the instrument.

The protein array reader “has the potential to overcome the relatively high cost concerns of existing microarray applications,” said Reinhard Hiller, managing director of the CPGR. “This creates an opportunity for developing affordable while at the same time reliable assays, something that is of critical importance in emerging markets such as South Africa.”

Hiller said that the CPGR intends to use the system to generate proof-of-concept data for a number of potential diagnostic applications in disease areas, such as tuberculosis, HIV/AIDS, malaria, asthma/COPD, and cancer.

Madison, Wis.-based Gentel said that it is seeking early-access partners to co-develop and commercialize novel biomarker panels using the system.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.